CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY (USD $)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Treasury Stock [Member]	Accumulated other comprehensive income [Member]	Equity Attributable To China Biologic Products, Inc. [Member]	Noncontrolling Interest [Member]
Balance at Dec. 31, 2012	$ 257,419,164	$ 2,663	$ 62,251,731	$ 119,143,000	$ 0	$ 14,072,322	$ 195,469,716	$ 61,949,448
Balance (in shares) at Dec. 31, 2012		26,629,615
Net income	64,837,968	0	0	45,773,809	0	0	45,773,809	19,064,159
Other comprehensive income	7,810,690	0	0	0	0	6,404,997	6,404,997	1,405,693
Dividend declared by subsidiaries to noncontrolling interest	(10,896,678)	0	0	0	0	0	0	(10,896,678)
Acquisition of noncontrolling interests	(1,963,913)	0	(664,662)	0	0	0	(664,662)	(1,299,251)
Share repurchase	(29,594,080)	0	0	0	(29,594,080)	0	(29,594,080)	0
Share repurchase (in shares)		0
Share-based compensation	4,076,817	0	4,076,817	0	0	0	4,076,817	0
Exercise of stock options	3,035,011	35	3,034,976	0	0	0	3,035,011	0
Exercise of stock options (in shares)		353,191
Vesting of restricted shares	0	6	(6)	0	0	0	0	0
Vesting of restricted shares (in shares)		63,750
Balance at Sep. 30, 2013	$ 294,724,979	$ 2,704	$ 68,698,856	$ 164,916,809	$ (29,594,080)	$ 20,477,319	$ 224,501,608	$ 70,223,371
Balance (in shares) at Sep. 30, 2013		27,046,556